Potential strategies utilised by papillomavirus to evade host immunity
- 28 April 1999
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 168 (1) , 131-142
- https://doi.org/10.1111/j.1600-065x.1999.tb01288.x
Abstract
Summary: The co‐evolution of papillomaviruses (PV) and their mammalian hosts has produced mechanisms by which PV might avoid specific and non‐specific host immune responses. Low level expression of PV proteins in infected basal epithelial cells, together with an absence of inflammation and of virus‐induced cell lysis, restricts the opportunity for effective PV protein presentation to immunocytes by dendritic cells. Additionally, PV early proteins, by a range of mechanisms, may restrict the efficacy of antigen presentation by these cells. Should an immune response be induced lo PV antigens, resting keratinocytes (KC) appear resistant to interferon‐γ‐enhanced mechanisms of cytotoxic T‐lymphocyte (CTL)‐mediated lysis, and expression of PV antigens by resting KC can tolerise PV‐specific CTL. Thus, KC, in the absence of inflammation, may represent an immunologically privileged site for PV infection. Together, these mechanisms play a part in allowing persistence of PV‐induced proliferative skin lesions for months to years, even in immunocompetent hosts.Keywords
This publication has 86 references indexed in Scilit:
- Transforming Growth Factor β1, in the Presence of Granulocyte/Macrophage Colony-stimulating Factor and Interleukin 4, Induces Differentiation of Human Peripheral Blood Monocytes into Dendritic Langerhans CellsThe Journal of Experimental Medicine, 1998
- AU-rich mRNA instability elements on human papillomavirus type 1 late mRNAs and c-fos mRNAs interact with the same cellular factorsOncogene, 1997
- T cell tolerance and activation to a transgene‐encoded tumor antigenEuropean Journal of Immunology, 1996
- One Step Ahead of the Game: Viral Immunomodulatory MoleculesAnnual Review of Immunology, 1996
- CULTURED MOUSE KERATINOCYTE ALLOGRAFTS PRIME FOR ACCELERATED SECOND SET REJECTION AND ENHANCED CYTOTOXIC LYMPHOCYTE RESPONSE1,2Transplantation, 1994
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- Interferon-Dependent Signaling Pathways: DNA Elements, Transcription Factors, Mutations, and Effects of Viral ProteinsJournal of Interferon Research, 1992
- Immune status as a determinant of human papillomavirus detection and its association with anal epithelial abnormalitiesInternational Journal of Cancer, 1990
- Susceptibility of human male keratinocytes to MHC-restricted H-Y-specific lysis.The Journal of Experimental Medicine, 1989
- Human papillomavirus infections in a group of renal transplant recipientsBritish Journal of Dermatology, 1986